E Fund Management Co., Ltd.

Position in OCGN — Ocugen, Inc.

CIK 1842296 GUANGZHOU, F4

Position in OCGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$83,870

+$19,503 QoQ

Shares Held

54,817

+54.1% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 147 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

E Fund Management Co., Ltd. holds $66,669,985 across 110 Biotechnology names. OCGN ranks #100 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,455	$5,690,042
2	ERAS	Erasca, Inc.	265,381	$4,861,779
3	CELC	Celcuity Inc.	45,895	$4,801,534
4	EYPT	EyePoint, Inc.	330,774	$4,730,068
5	AVBP	ArriVent BioPharma, Inc.	109,328	$3,798,054
6	REGN	Regeneron Pharmaceuticals, Inc.	5,158	$3,216,219
7	LEGN	Legend Biotech Corp	109,327	$3,157,363
8	ALNY	Alnylam Pharmaceuticals, Inc.	6,073	$1,828,155

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$83,870	54,817	+54.1%	Shares	Sole	2026-08-11
2026-03-31	$64,367	35,562	-30.6%	Shares	Sole	2026-04-13
2024-09-30	$50,817	51,227	+5.8%	Shares	Sole	2024-11-13
2024-06-30	$75,038	48,412	-62.6%	Shares	Sole	2024-08-12
2022-12-31	$168,347	129,498	-2.6%	Shares	Sole	2023-02-14
2022-09-30	$236,629	132,938	-16.3%	Shares	Sole	2022-11-14
2022-06-30	$360,666	158,884	+45.1%	Shares	Sole	2022-08-15
2022-03-31	$361,310	109,488	+239.5%	Shares	Sole	2022-05-12
2021-12-31	$146,755	32,254	+33.8%	Shares	Sole	2022-02-11
2021-09-30	$173,102	24,109	+73.9%	Shares	Sole	2021-11-12
2021-03-31	$94,150	13,866	—	Shares	Sole	2021-05-13
No filing history on record for this holder in this stock.